Amneal Pharmaceuticals AMRX
Last Price
52 Week Range
$6.69 - $13.01
Next Earnings Date
Feb 27 2026 (Estimate)
Next Earnings Date
Feb 27 2026 (Est.)
Last Price
AMRX Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
Amneal Pharmaceuticals, Inc. | 10-Q | November 6, 2025 | |
Amneal Pharmaceuticals, Inc. | 8-K | October 30, 2025 | |
Amneal Pharmaceuticals, Inc. | 10-Q | August 7, 2025 | |
Amneal Pharmaceuticals, Inc. | 8-K | August 5, 2025 | |
Amneal Pharmaceuticals, Inc. | 8-K | August 1, 2025 | |
Amneal Pharmaceuticals, Inc. | 8-K | July 24, 2025 | |
Amneal Pharmaceuticals, Inc. | 8-K | July 21, 2025 | |
Amneal Pharmaceuticals, Inc. | 8-K | July 21, 2025 | |
Amneal Pharmaceuticals, Inc. | 8-K | May 8, 2025 | |
Amneal Pharmaceuticals, Inc. | 10-Q | May 7, 2025 | |
Amneal Pharmaceuticals, Inc. | 8-K | May 2, 2025 | |
Amneal Pharmaceuticals, Inc. | DEF 14A | March 25, 2025 | |
Amneal Pharmaceuticals, Inc. | DEFA14A | March 25, 2025 | |
Amneal Pharmaceuticals, Inc. | 8-K | March 6, 2025 | |
Amneal Pharmaceuticals, Inc. | 10-K | February 28, 2025 | |
Amneal Pharmaceuticals, Inc. | 8-K | February 28, 2025 | |
Amneal Pharmaceuticals, Inc. | 8-K | January 15, 2025 | |
Amneal Pharmaceuticals, Inc. | 10-Q | November 12, 2024 | |
Amneal Pharmaceuticals, Inc. | 8-K | November 8, 2024 | |
Amneal Pharmaceuticals, Inc. | 8-K | October 1, 2024 | |
Amneal Pharmaceuticals, Inc. | 8-K | August 9, 2024 | |
Amneal Pharmaceuticals, Inc. | 10-Q | August 9, 2024 | |
Amneal Pharmaceuticals, Inc. | 10-Q | May 8, 2024 | |
Amneal Pharmaceuticals, Inc. | 8-K | May 7, 2024 | |
Amneal Pharmaceuticals, Inc. | 8-K | May 3, 2024 | |
Amneal Pharmaceuticals, Inc. | DEFA14A | March 22, 2024 | |
Amneal Pharmaceuticals, Inc. | DEF 14A | March 22, 2024 | |
Amneal Pharmaceuticals, Inc. | 10-K | March 14, 2024 | |
Amneal Pharmaceuticals, Inc. | 8-K | March 1, 2024 | |
Amneal Pharmaceuticals, Inc. | 8-K | January 10, 2024 |
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.